Kirk Dornbush
Oprichter bij Iconic Therapeutics, Inc.
Profiel
Kirk Dornbush is the founder and the Director of Iconic Therapeutics, Inc., which was founded in 2003.
He is currently a Manager at Diem Bioventures LLC.
Mr. Dornbush has an undergraduate degree from The Colorado College and a graduate degree from Boston University School of Law.
Actieve functies van Kirk Dornbush
| Bedrijven | Functie | Begin |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Oprichter | 01-01-2003 |
Diem Bioventures LLC
 Diem Bioventures LLC Investment ManagersFinance Diem Bioventures LLC provides investment advisory services. The company was founded on January 28, 2003 and is headquartered in Highlands, NC. | Corporate Officer/Principal | - |
Opleiding van Kirk Dornbush
| The Colorado College | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Diem Bioventures LLC
Diem Bioventures LLC Investment ManagersFinance Diem Bioventures LLC provides investment advisory services. The company was founded on January 28, 2003 and is headquartered in Highlands, NC. | Finance |
